MIRM

Mirum Pharmaceuticals Inc.

Price

$102.24

return (12m)

56.91%

p/e

-7.25

p/bv

-598.53

DIVIDEND YIELD

0.00%

MIRM price

Mirum Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MIRM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-12.65%

3 months

1.56%

1 year

56.91%

2 years

144.42%

5 years

621.02%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals MIRM

Valuation

P/E

-7.25

Sector -4.38

Industry -4.38

P/BV

-598.53

Sector 2.02

Industry 2.02

P/Revenue (PSR)

10.09

Sector -4.40

Industry -4.40

EV/EBITDA

-116.98

Sector -263.09

Industry -263.09

EV/EBIT

-104.08

Sector -702.90

Industry -702.90

P/EBITDA

-7.62

Sector -4.39

Industry -4.39

P/EBIT

-7.39

Sector -4.73

Industry -4.73

P/Total Assets

5.97

Sector 1.49

Industry 1.49

P/Net Current Assets

-14.88

Sector -11.70

Industry -11.70

P/Working Capital

15.08

Sector -3.19

Industry -3.19

EPS

-13.65

Sector -2.14

Industry -2.14

BVPS

-0.17

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

81.73%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-31.76%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-35.70%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-14.76%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.17

Sector 0.03

Industry 0.03

Profitability

ROE

8,255.37%

Sector -65.14%

Industry -65.14%

ROA

-82.32%

Sector -65.53%

Industry -65.53%

ROIC

-24.59%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.86

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-5.57

Sector -6.07

Industry -6.07

Net Debt / EBIT

-4.96

Sector -8.26

Industry -8.26

Net Debt / Equity

-29.92

Sector -1.07

Industry -1.07

Gross Debt / Equity

-71.98

Sector -0.05

Industry -0.05

Equity/Assets

-0.01

Sector 0.41

Industry 0.41

Liabilities/Assets

1.01

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

100.36%

Sector -

Industry -

5Y Earnings CAGR

59.25%

Sector -

Industry -

Fundamentals MIRM

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MIRM Mirum Pharmaceuticals Inc.	$102.24	53.33%	0.00%	-7.25	-598.53	8,255.37%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MIRM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Mirum Pharmaceuticals

Mirum Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

8 years

Founded: 2018

2019

Time since IPO - 7 years

33

Employees

Mirum Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $6.24 billion, with shareholders equity totaling $-10.42 million.

The company employs approximately 33 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Mirum Pharmaceuticals Inc. reported $618.06 million in revenue, generating net income of $-860.21 million.

Key financial metrics include a P/E ratio of -7.25, a price-to-book (P/B) ratio of -598.53, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MIRM.

Market cap

$6.24 billion

Net worth

$-10.42 million

$-10,420,000.00

Assets

$1.04 billion

$1,044,980,000.00

Total Shares Outstanding

63.00 million

63,000,000

Average Daily Trading Volume

$860.68 Thousand

$860,683.42

Sector

Health Care

Industry

Biotechnology

MIRM

MIRM revenue and profits

Financial Results MIRM

DRAG THE FRAME TO SEE MORE DATA

MIRM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Mirum Pharmaceuticals (MIRM) today?

A cotação de Mirum Pharmaceuticals (MIRM) hoje está em US$ 102.24, com uma variação de 56.91% em relação ao último ano. A cotação de Mirum Pharmaceuticals (MIRM) iniciou o ano negociando na casa dos US$ 78.99 e hoje está em US$ 102.24. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Mirum Pharmaceuticals (MIRM) e dados de ações do Ibovespa e mercados internacionais.

Quando Mirum Pharmaceuticals (MIRM) paga dividendos?

Mirum Pharmaceuticals (MIRM) não distribuiu dividendos no último ano.

Is Mirum Pharmaceuticals (MIRM) a good investment?

Atualmente, Mirum Pharmaceuticals (MIRM) está cotada a US$ 102.24, com um P/L de -7.25, representando um desvio de -4,380% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 56.91 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 56.91%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Mirum Pharmaceuticals (MIRM) stock?

Investir em ações de Mirum Pharmaceuticals (MIRM) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Mirum Pharmaceuticals (MIRM) yield today?

A rentabilidade de Mirum Pharmaceuticals (MIRM) foi de -12.65% no último mês, 56.91% no último ano e 621.02% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Mirum Pharmaceuticals (MIRM) hoje, o investimento total seria de US$ 10,224.00, com base na cotação atual de US$ 102.24.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 16,042.48
Em 5 anos: US$ 73,717.08
Em 10 anos: US$ 10,224.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MIRM

Mirum Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MIRM

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING MIRM WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Mirum Pharmaceuticals

Mirum Pharmaceuticals Inc.

United States

8 years

2019

33

PROFIT X PRICE MIRM

Financial Results MIRM

MIRM cash flow

Asset, Revenue and Profit Growth - MIRM

MIRM balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions